Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403494
Status:
COMPLETED
Last Update Posted:
2021-01-07
First Post:
2006-11-21
Brief Title:
A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Organization Data
Organization:
BioMarin Pharmaceutical
Class:
INDUSTRY
Study ID:
PAD-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioMarin Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None